Clinical Trial Update: A/H5N1in Adult - Aventis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update for an A/H5N1 influenza vaccine in adults; the Aventis-sponsored study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• A/H5N1 influenza vaccine (influenza vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza | Phase 1, Phase 2 | Status: COMPLETED